- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05248503
Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB) (FIREB)
Hereditary epidermolysis bullosa (EBH) is a rare, orphan disease characterized by skin and mucous membrane fragility.
The latest scientific data show that the proposed treatments are still in the experimental stage and that no curative treatment is available. The repercussions of this chronic disease, with neonatal onset, are major.
Epidermolysis bullosa requires multidisciplinary medical management, nursing care, psychological and social care.
Skin care involves preventing and treating chronic wounds and identifying their complications. The very great cutaneous-mucous fragility makes these treatments painful, long and complex, the caring hand itself being able to cause new wounds. Analgesics of different levels are not effective enough during treatment.
Along with counseling and education, nursing takes a central role in multi-professional accompaniment interventions to support and relieve families.
Parents became home caregivers out of necessity, and developed specific skills in epidermolysis bullosa, their child and dressings. They have great and demanding expectations of caregivers facing this rare disease, for which they are not trained in their degree course. Despite the severe nature of the disease, few studies have been carried out on the impact and psychosocial consequences on patients and their families, yet there is an expressed need for support.
The burden on parents is heavy, assessed by specific scales, but to date there are no studies examining the impact of epidermolysis bullosa care on caregiver stress.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sandrine COMPAIN, RN
- Phone Number: +33 1 44 49 45 95
- Email: sandrine.compain@aphp.fr
Study Contact Backup
- Name: Solimda SOTOU BERE
- Phone Number: + 33 1 42 19 28 79
- Email: solimda.sotoubere@aphp.fr
Study Locations
-
-
-
Paris, France, 75015
- Recruiting
- Assistance Publique - Hôpitaux de Paris
-
Contact:
- Sandrine Compain, nurse
- Phone Number: +33 1 44 49 45 95
- Email: sandrine.compain@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Nurse, nursing assistant, nursery nurse, childcare assistant, state graduates caring for patients with EBH and working at Necker Hospital.
- Having participated in the entire training program specific to the complex care of epidermolysis bullosa.
- Informed and not opposed to their participation in research.
Exclusion Criteria
- Person under tutorship or curatorship.
- Other health professionals (physiotherapist, doctor, etc.).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Nurse
Pediatric nurses taking charge of the care of patients with epidermolysis bullosa at Necker Hospital
|
Training in the care of epidermolysis bullosa by combining theoretical content on the disease and practical workshops.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of anxiety level
Time Frame: Change form baseline (before training) and at the end of the second day of training
|
Anxiety will be assessed using the Anxiety - Spielberger State self-quiz, rated from 20 to 80 (80 indicating maximum anxiety state).
|
Change form baseline (before training) and at the end of the second day of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety evolution
Time Frame: 3 months after training
|
Anxiety will be assessed using the Anxiety - Spielberger State self-quiz, rated from 20 to 80 (80 indicating maximum anxiety state).
|
3 months after training
|
Anxiety auto-evaluation
Time Frame: Before training. 3 and 6 months after the training
|
Self-assessment of factors that may induce anxiety measured on a Likert Scale from 0 to 4 (4 indicating a factors induces an high level of anxiety)
|
Before training. 3 and 6 months after the training
|
Feeling of skills
Time Frame: Before training. 3 and 6 months after the training
|
Self-assessment of feeling of skills on Likert scales from 0 to 4 (4 indicating a factors induces an high level of anxiety)
|
Before training. 3 and 6 months after the training
|
Nurse knowledge about Epidermolysis bullosa
Time Frame: Before and after the training. 3 and 6 months after the training
|
A true/false questionnaire with degree of certainty assessing knowledge about epidermolysis bullosa
|
Before and after the training. 3 and 6 months after the training
|
Satisfaction questionnaire
Time Frame: At the end of the second day of training.
|
Satisfaction questionnaire on the quality and content of the training with a Likert scale ( 0 to 5; an higher score indicates better outcome) and open questions.
|
At the end of the second day of training.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sandrine COMPAIN, RN, Necker Hospital, APHP
Publications and helpful links
General Publications
- Ingen-Housz-Oro S, Blanchet-Bardon C. Épidermolyses bulleuses héréditaires. EMC - Dermatol-Cosmétologie. 1 févr 2004 ; 1(1) :2 18.
- Chiaverini C, Bourrat E, Mazereeuw-Hautier J, Hadj-Rabia S, Bodemer C, Lacour JP. [Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment]. Ann Dermatol Venereol. 2017 Jan;144(1):6-35. doi: 10.1016/j.annder.2016.07.016. Epub 2016 Dec 5. French.
- Lustre A, Levé-Corset I, Leeuwin G, Launay C, Blondy MF, Michaud MT, et al. Soins infirmiers de l'épidermolyse bulleuse. Rev Fr Allergol Immunol Clin. 2001 ; 41(7) : 659-663.
- Jérôme Palazzolo, Julie Arnaud, Anxiété et performance : de la théorie à la pratique, Annales Médico-psychologiques, revue psychiatrique, Elsevier, Volume 171, Issue 6, July 2013, Pages 382-388.
- Bandura, A. Auto-efficacité. Le sentiment d'efficacité personnelle (Trad. J. Lecomte). Bruxelles : De Boeck. 2003.
- Gadbois, C., Aides-soignantes et infirmières de nuit, conditions de travail et vie quotidienne, Paris : Etudes et Recherches, 1981.
- Van Daele A., Le stress chez les médecins généralistes : une approche transactionnelle, In B. Gangloff (Ed.), satisfactions et souffrances au travail (60-67), Paris : l'Harmattan.
- Verquerre R., Rusinek-Nisot, Etude du stress chez des infirmiers, In R.Jacob et R. Laflamme (Eds), Stress, santé et intervention au travail, (61-71), Québec : Presses Inter Universitaires.
- Borteyrou X, Bruchon-Schweitzer M, Spielberger CD. [The French adaptation of the STAXI-2, C.D. Spielberger's State-trait anger expression inventory]. Encephale. 2008 Jun;34(3):249-55. doi: 10.1016/j.encep.2007.06.001. Epub 2007 Oct 10. French.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP211522
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hereditary Epidermolysis Bullosa
-
Castle Creek Pharmaceuticals, LLCCompletedDystrophic Epidermolysis Bullosa | Epidermolysis Bullosa Simplex | Junctional Epidermolysis Bullosa | Epidermolysis Bullosa (EB)United States
-
Krystal Biotech, Inc.CompletedDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa | DEB - Dystrophic Epidermolysis BullosaUnited States
-
Krystal Biotech, Inc.CompletedDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis BullosaUnited States
-
Castle Creek Biosciences, LLC.TerminatedEpidermolysis Bullosa Dystrophica, RecessiveUnited States
-
Instituto de Investigación Hospital Universitario...Instituto de Salud Carlos III; Universidad Carlos III Madrid (TERMeG); St John... and other collaboratorsUnknownEpidermolysis Bullosa Dystrophica, RecessiveSpain
-
Lenus Therapeutics, LLCTerminatedDystrophic Epidermolysis Bullosa | Junctional Epidermolysis BullosaUnited States
-
Holostem Terapie Avanzate s.r.l.IRCCS San Raffaele; University of Modena and Reggio EmiliaRecruitingJunctional Epidermolysis Bullosa Non-Herlitz TypeFrance, Italy
-
Krystal Biotech, Inc.RecruitingDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis BullosaUnited States
-
Phoenicis TherapeuticsNot yet recruitingDystrophic Epidermolysis BullosaUnited States
-
Thomas Jefferson UniversityOnconova Therapeutics, Inc.RecruitingRecessive Dystrophic Epidermolysis BullosaUnited States
Clinical Trials on Complex Care Training of Hereditary Epidermolysis Bullosa
-
OPKO IP Holdings II, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal InsufficiencyUnited States
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
Umeå UniversityKarolinska Institutet; Lund University; Göteborg UniversityEnrolling by invitationLynch Syndrome | Hereditary Breast and Ovarian Cancer Syndrome | Familial Breast Cancer | Hereditary Breast Cancer | Familial Colorectal CancerSweden
-
Universiti Putra MalaysiaRecruiting
-
The Hospital for Sick ChildrenHamilton Health Sciences Corporation; London Health Sciences Centre; Children...Completed
-
Heinrich-Heine University, DuesseldorfLudwig-Maximilians - University of Munich; Federal Ministry of Health, Germany and other collaboratorsCompletedNursing Homes | Advance Care PlanningGermany
-
Bridge to Health Medical and DentalUniversity of Toronto; Kigezi Healthcare FoundationUnknownPneumonia | Pediatric Disorder | Diagnostic and Monitoring Radiological Devices Associated With Adverse IncidentsUganda
-
NYU Langone HealthCompletedCardiovascular Disease | Type 2 Diabetes (T2DM)United States
-
Mayo ClinicCompletedPhysical Activity | Body Weight Changes | Overweight and ObesityUnited States
-
Istanbul UniversityActive, not recruiting